Diagnosis and treatment of men with prostate cancer during the COVID-19 pandemic: a national population based study in England
BAUS ePoster online library. Nossiter J. 06/21/21; 319058; p2-1
Disclosure(s): None
Dr. Julie Nossiter
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Introduction
The COVID-19 pandemic has had a profound impact on cancer care. We evaluated the impact on the diagnosis and treatment of men with prostate cancer (PCa) in England.
Patients/Methods
Patients diagnosed with PCa in the English NHS between 1st January 2019 and 30th June 2020 (N=58,749) were identified in the Rapid Cancer Registration dataset. Patient-level linkage to the Cancer Waiting Times dataset provided information on radical surgery and radiotherapy within 12 months of diagnosis. Follow-up was available to 31st July 2020. Changes in monthly diagnoses and treatments following the start of the UK lockdown on 23rd March 2020 were compared with the corresponding month in 2019.
Results
Overall, there was a 56% reduction in diagnoses compared with 2019 (55% in April, 62% in May and 51% in June). Radical surgery also declined (by 61% in April, 60% in May) with a relatively greater reduction in radiotherapy (by 75% in April, 69% in May) compared with 2019. Radical treatment activity increased from June with a one third reduction compared with 2019 in radical surgery (34%) and radiotherapy (33%) by July.
Conclusion
Diagnostic and radical treatment activity fell significantly following the UK lockdown. There was evidence of a recovery in surgical and radiotherapy activity in June although this was not complete by the end of July 2020. Follow-up to September 2020 and linkage to routine hospital datasets (HES, RTDS and SACT) will allow further exploration of treatment patterns and their recovery. These analyses will be completed by the time of presentation.
The COVID-19 pandemic has had a profound impact on cancer care. We evaluated the impact on the diagnosis and treatment of men with prostate cancer (PCa) in England.
Patients/Methods
Patients diagnosed with PCa in the English NHS between 1st January 2019 and 30th June 2020 (N=58,749) were identified in the Rapid Cancer Registration dataset. Patient-level linkage to the Cancer Waiting Times dataset provided information on radical surgery and radiotherapy within 12 months of diagnosis. Follow-up was available to 31st July 2020. Changes in monthly diagnoses and treatments following the start of the UK lockdown on 23rd March 2020 were compared with the corresponding month in 2019.
Results
Overall, there was a 56% reduction in diagnoses compared with 2019 (55% in April, 62% in May and 51% in June). Radical surgery also declined (by 61% in April, 60% in May) with a relatively greater reduction in radiotherapy (by 75% in April, 69% in May) compared with 2019. Radical treatment activity increased from June with a one third reduction compared with 2019 in radical surgery (34%) and radiotherapy (33%) by July.
Conclusion
Diagnostic and radical treatment activity fell significantly following the UK lockdown. There was evidence of a recovery in surgical and radiotherapy activity in June although this was not complete by the end of July 2020. Follow-up to September 2020 and linkage to routine hospital datasets (HES, RTDS and SACT) will allow further exploration of treatment patterns and their recovery. These analyses will be completed by the time of presentation.
Introduction
The COVID-19 pandemic has had a profound impact on cancer care. We evaluated the impact on the diagnosis and treatment of men with prostate cancer (PCa) in England.
Patients/Methods
Patients diagnosed with PCa in the English NHS between 1st January 2019 and 30th June 2020 (N=58,749) were identified in the Rapid Cancer Registration dataset. Patient-level linkage to the Cancer Waiting Times dataset provided information on radical surgery and radiotherapy within 12 months of diagnosis. Follow-up was available to 31st July 2020. Changes in monthly diagnoses and treatments following the start of the UK lockdown on 23rd March 2020 were compared with the corresponding month in 2019.
Results
Overall, there was a 56% reduction in diagnoses compared with 2019 (55% in April, 62% in May and 51% in June). Radical surgery also declined (by 61% in April, 60% in May) with a relatively greater reduction in radiotherapy (by 75% in April, 69% in May) compared with 2019. Radical treatment activity increased from June with a one third reduction compared with 2019 in radical surgery (34%) and radiotherapy (33%) by July.
Conclusion
Diagnostic and radical treatment activity fell significantly following the UK lockdown. There was evidence of a recovery in surgical and radiotherapy activity in June although this was not complete by the end of July 2020. Follow-up to September 2020 and linkage to routine hospital datasets (HES, RTDS and SACT) will allow further exploration of treatment patterns and their recovery. These analyses will be completed by the time of presentation.
The COVID-19 pandemic has had a profound impact on cancer care. We evaluated the impact on the diagnosis and treatment of men with prostate cancer (PCa) in England.
Patients/Methods
Patients diagnosed with PCa in the English NHS between 1st January 2019 and 30th June 2020 (N=58,749) were identified in the Rapid Cancer Registration dataset. Patient-level linkage to the Cancer Waiting Times dataset provided information on radical surgery and radiotherapy within 12 months of diagnosis. Follow-up was available to 31st July 2020. Changes in monthly diagnoses and treatments following the start of the UK lockdown on 23rd March 2020 were compared with the corresponding month in 2019.
Results
Overall, there was a 56% reduction in diagnoses compared with 2019 (55% in April, 62% in May and 51% in June). Radical surgery also declined (by 61% in April, 60% in May) with a relatively greater reduction in radiotherapy (by 75% in April, 69% in May) compared with 2019. Radical treatment activity increased from June with a one third reduction compared with 2019 in radical surgery (34%) and radiotherapy (33%) by July.
Conclusion
Diagnostic and radical treatment activity fell significantly following the UK lockdown. There was evidence of a recovery in surgical and radiotherapy activity in June although this was not complete by the end of July 2020. Follow-up to September 2020 and linkage to routine hospital datasets (HES, RTDS and SACT) will allow further exploration of treatment patterns and their recovery. These analyses will be completed by the time of presentation.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}